Allscripts Healthcare Solutions, Inc. (MDRX) Raised to “Overweight” at Cantor Fitzgerald

Cantor Fitzgerald upgraded shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) from a neutral rating to an overweight rating in a research report sent to investors on Tuesday, MarketBeat.com reports. The brokerage currently has $12.00 target price on the software maker’s stock.

Other equities analysts have also issued research reports about the stock. Bank of America Corporation assumed coverage on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. They issued a neutral rating and a $14.00 price objective on the stock. Citigroup Inc. boosted their price objective on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a neutral rating in a report on Monday, August 7th. BidaskClub upgraded shares of Allscripts Healthcare Solutions from a sell rating to a hold rating in a report on Saturday, June 24th. Leerink Swann lowered shares of Allscripts Healthcare Solutions from an outperform rating to a market perform rating and cut their price objective for the stock from $15.00 to $13.00 in a report on Monday, June 19th. Finally, Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a sell rating to a hold rating in a report on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the stock. The company has an average rating of Hold and an average price target of $14.59.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 12.85 on Tuesday. Allscripts Healthcare Solutions has a 12-month low of $9.80 and a 12-month high of $13.70. The stock’s market cap is $2.32 billion. The company has a 50-day moving average price of $12.51 and a 200 day moving average price of $12.21.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by $0.04. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The firm had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. During the same quarter in the prior year, the firm earned $0.14 EPS. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, equities research analysts predict that Allscripts Healthcare Solutions will post $0.62 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Raised to “Overweight” at Cantor Fitzgerald” was first reported by BNB Daily and is owned by of BNB Daily. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.baseball-news-blog.com/2017/08/19/allscripts-healthcare-solutions-inc-mdrx-raised-to-overweight-at-cantor-fitzgerald.html.

Several large investors have recently made changes to their positions in the stock. Archford Capital Strategies LLC increased its stake in shares of Allscripts Healthcare Solutions by 6,124.0% in the second quarter. Archford Capital Strategies LLC now owns 6,224 shares of the software maker’s stock worth $958,000 after buying an additional 6,124 shares in the last quarter. FNY Partners Fund LP increased its stake in shares of Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock worth $101,000 after buying an additional 7,200 shares in the last quarter. Invictus RG acquired a new stake in shares of Allscripts Healthcare Solutions during the first quarter worth $105,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Allscripts Healthcare Solutions by 9.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock worth $120,000 after buying an additional 816 shares in the last quarter. Finally, Bank of Montreal Can increased its stake in shares of Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after buying an additional 3,724 shares in the last quarter.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply